lung permeabl leukotrien interleukin IL therapi dysfunct due vascular permeabl studi role chemoattract immunomodul permeability-promot agent leukotrien LT set sheep chronic lung lymph fistula u/kg IV bolu hour signific increas level plasma lung lymph mean pulmonari arteri pressur mpap pulmonari arteri wedg pressur unchang arteri oxygen tension lung lymph flow QL hour increas lymph/plasma l/p protein ratio increas lymph protein clearanc data microvascular permeabl mild leukopenia thrombocytopenia bodi temperatur chill common pretreat lipoxygenas inhibitor diethylcarbamazin dec baselin plasma level increas plasma lung lymph contrast treatment dec increas mpap rise QL l/p protein ratio lymph protein clearanc dec leukopenia fall platelet count rise bodi temperatur infus excipi control plasma lymph level mild increas mpap QL l/p protein ratio bodi temperatur leukocyt platelet count unaffect data administr pulmonari dysfunct pulmonari hypertens vascular permeabl event synthesi leukotrien lung injuri 